ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of acute myeloblastic leukemia (AML) in adult patients

M F Fey; Richard Greil; L M Jost

doi:10.1093/annonc/mdi802

ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of acute myeloblastic leukemia (AML) in adult patients

M F Fey, Richard Greil (Co-author), L M Jost

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Short comment / notes › peer-review

4 Citations (Web of Science)

Original language	English
Pages (from-to)	48-49
Journal	ANNALS OF ONCOLOGY
Volume	16
DOIs	https://doi.org/10.1093/annonc/mdi802
Publication status	Published - 2005

Keywords

ACUTE PROMYELOCYTIC LEUKEMIA
ACUTE MYELOID-LEUKEMIA
TRANS-RETINOIC ACID
CHEMOTHERAPY

Access to Document

10.1093/annonc/mdi802

Cite this

Fey, M. F., Greil, R., & Jost, L. M. (2005). ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of acute myeloblastic leukemia (AML) in adult patients. ANNALS OF ONCOLOGY , 16, 48-49. https://doi.org/10.1093/annonc/mdi802

Fey, M F ; Greil, Richard ; Jost, L M. / ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of acute myeloblastic leukemia (AML) in adult patients. In: ANNALS OF ONCOLOGY 2005 ; Vol. 16. pp. 48-49.

@article{fb0db165591c4ad682a9cdf30d466d89,

title = "ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of acute myeloblastic leukemia (AML) in adult patients",

keywords = "ACUTE PROMYELOCYTIC LEUKEMIA, ACUTE MYELOID-LEUKEMIA, TRANS-RETINOIC ACID, CHEMOTHERAPY",

author = "Fey, {M F} and Richard Greil and Jost, {L M}",

note = "Greil: University Hospital Salzburg, Dept of Hematology/Oncology, Muellnerhauptstrasse 48, 5020 Salzburg, Austria",

year = "2005",

doi = "10.1093/annonc/mdi802",

language = "English",

volume = "16",

pages = "48--49",

journal = "ANNALS OF ONCOLOGY ",

issn = "0923-7534",

publisher = "Elsevier ",

}

Fey, MF, Greil, R & Jost, LM 2005, 'ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of acute myeloblastic leukemia (AML) in adult patients', ANNALS OF ONCOLOGY , vol. 16, pp. 48-49. https://doi.org/10.1093/annonc/mdi802

ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of acute myeloblastic leukemia (AML) in adult patients. / Fey, M F; Greil, Richard (Co-author); Jost, L M.
In: ANNALS OF ONCOLOGY , Vol. 16, 2005, p. 48-49.

Research output: Contribution to journal › Short comment / notes › peer-review

TY - JOUR

T1 - ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of acute myeloblastic leukemia (AML) in adult patients

AU - Fey, M F

AU - Greil, Richard

AU - Jost, L M

N1 - Greil: University Hospital Salzburg, Dept of Hematology/Oncology, Muellnerhauptstrasse 48, 5020 Salzburg, Austria

PY - 2005

Y1 - 2005

KW - ACUTE PROMYELOCYTIC LEUKEMIA

KW - ACUTE MYELOID-LEUKEMIA

KW - TRANS-RETINOIC ACID

KW - CHEMOTHERAPY

U2 - 10.1093/annonc/mdi802

DO - 10.1093/annonc/mdi802

M3 - Short comment / notes

C2 - 15888751

SN - 0923-7534

VL - 16

SP - 48

EP - 49

JO - ANNALS OF ONCOLOGY

JF - ANNALS OF ONCOLOGY

ER -

Fey MF, Greil R, Jost LM. ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of acute myeloblastic leukemia (AML) in adult patients. ANNALS OF ONCOLOGY . 2005;16:48-49. doi: 10.1093/annonc/mdi802